Interstitial lung disease in patients with rheumatoid arthritis: A comparison with cryptogenic fibrosing alveolitis

Rheumatology

Volumn 40, Issue 9, 2001, Pages 1022-1025

  Rajasekaran, B A ^a   Shovlin, D ^a   Lord, P ^a   Kelly, C A ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Cryptogenic fibrosing alveolitis; High resolution tomography; Interstitial lung disease; Rheumatoid arthritis

Indexed keywords

RHEUMATOID FACTOR;

ADULT; AGE; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLUBBING FINGERS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; EVIDENCE BASED MEDICINE; FEMALE; FIBROSING ALVEOLITIS; FORCED EXPIRATORY VOLUME; GAS DIFFUSION; GENDER; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; IMMUNOLOGY; INTERSTITIAL LUNG DISEASE; LONGITUDINAL STUDY; LUNG FUNCTION TEST; MALE; MEDICAL INFORMATION; PARAMETER; PHYSIOLOGY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RADIOLOGY; RHEUMATOID ARTHRITIS; SMOKING; SYMPTOM; VITAL CAPACITY;

AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY FIBROSIS; RADIOGRAPHY, THORACIC; RESPIRATORY FUNCTION TESTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0034789207     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Cryptogenic fibrosing alveolitis: Clinical features and their influence on survival
2. Prognosis of cryptogenic fibrosing alveolitis
3. The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults
4. Rheumatoid arthritis, classical lung disease
5. High definition computed tomography in rheumatoid arthritis associated pulmonary disease
6. High resolution computed tomography of the lungs in patients with rheumatoid arthritis and interstitial lung disease
7. The role of high resolution computed tomography in the diagnosis of interstitial lung disease
8. High resolution computed tomography as a predictor of lung histology in systemic sclerosis
9. Interstitial pneumonia and its consequences in rheumatoid disease
10. Diffuse interstitial pulmonary fibrosis associated with arthritis
11. Pulmonary involvement in rheumatoid arthritis
12. Pulmonary fibrosis in rheumatoid arthritis: A review of clinical features and therapy
13. Pulmonary involvement in rheumatoid arthritis
14. Technetium-99m-DTPA aerosol to measure alveolar capillary membrane permeability
15. Cryptogenic fibrosing alveolitis: Response to corticosteroid treatment and its effect on survival
16. Systemic artery patterns in the lung and clubbing of the fingers
17. Antibodies to nuclear ribonucleoprotein in cryptogenic fibrosing alveolitis, a subset with mixed connective diseases
18. Possible relationship of rheumatoid factors and pulmonary disease
19. Sero-positive rheumatoid arthritis associated with decreased diffusing capacity of the lungs
20. Cigarette smoking: A risk factor for idiopathic pulmonary fibrosis
21. Rheumatoid lung disease
22. Can baseline pulmonary function tests predict pulmonary toxicity in patients receiving methotrexate for rheumatoid arthritis
23. Effects of inflammation and fibrosis on pulmonary function in diffuse lung fibrosis
24. Fibrosing alveolitis: Prognostic implication of ground glass attenuation at high resolution CT
25. Idiopathic pulmonary fibrosis. Predicting response to therapy and survival
26. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis
27. Clearance of inhaled 99m-Tc DTPA predicts the clinical course of fibrosing alveolitis
28. Increased alveolar permeability in cigarette smokers
29. Use of sequential DTPA clearance and high resolution computed tomography in monitoring interstitial lung disease in dermatomyositis
30. Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis
31. In search of a cause for cryptogenic fibrosing alveolitis: One initiating factor or many?
32. Structural features of interstitial lung disease in systemic sclerosis
33. Idiopathic pulmonary fibrosis and pulmonary fibrosis in diffuse systemic sclerosis: Two fibroses with different prognoses